An esophageal foreign body has clinical significance because it may cause serious complications such as esophageal perforation, mediastinitis and/or aorto-esophageal fistula. A prompt attempt to remove an esophageal foreign body via flexible endoscopy should be made when the shape of the foreign body is especially sharp and long as it can easily lead to esophageal perforation. We report here on a case of endoscopic removal of an impacted esophageal foreign body, a fishhook, that hade been present in the esophagus for two months, and there were no serious complications from the procedure.
Endoscopy ; Epoxy Compounds ; Esophageal Perforation ; Esophagus ; Fistula ; Foreign Bodies ; Hydroxybenzoate Ethers ; Mediastinitis

No abstract available.
Hemorrhage ; Metoclopramide

No abstract available.
Blood Pressure* ; Metoclopramide* ; Rabbits*

This clinical trial was undertaken on 32 infants and chhildren who had G-I symptoms caused by a few diseases, such as meningitis, parenteral infection and intestinal infection. Out of 32 patients, six had vomiting only, caused by meingitis and habitual vomiting, eighteen had vomiting and diarrhea both which caused by parenteral infection and rest of them (8) had diarrhea only, caused by intestinal infection. Polybutine syrup, which 5.0 ml contain 24 mg of trimebutine, was given to these patients as follows; 2.5 ml twice a day at 6 months of age, 5.0 ml twice a day at 6 months to one year and 10 ml three times a day at 1-5 years of age. In ten of 24 patients, who had vomiting only (6), vomiting and diarrhea (18), the symptoms were improved within 48 hours, and rest of them (10) was also shown the improvement of their symptoms within 5 days after medication. In comparison of polybutine treated group and not treated group, the effectiveness of polybutine treatment for the symptoms was statistically meaningful.
Diarrhea ; Humans ; Infant ; Meningitis ; Trimebutine ; Vomiting

No abstract available.
Dyspepsia ; Gastroesophageal Reflux ; Helicobacter pylori ; Helicobacter ; Trimebutine

No abstract available.
Antiemetics* ; Cisplatin* ; Dexamethasone* ; Humans ; Lorazepam* ; Metoclopramide* ; Ondansetron*

No abstract available.
Disorders of Excessive Somnolence ; Humans ; Metoclopramide ; Parkinsonian Disorders

No abstract available.
Drug Therapy, Combination* ; Metoclopramide* ; Ondansetron* ; Prospective Studies* ; Vomiting*

Methods: In a randomized, double-blinded, placebo-controlled trial, 144 ASA I-II patients, scheduled for elective surgery under general anesthesia were randomly assigned to 1 of 4 groups. Group I received 2 ml of plain NSS, group II received lidocaine 40 mg, group III received thiopental 0.5mg/kg and group IV received metoclopramide 10 mg. All pretreatment drugs were made into 2 ml solutions and were given IV with manual venous occlusion of 1 minute. Propofol was administered after release of venous occlusion. pain was then assessed using a four-point scale and face pain scale during propofol injection. Results: 36 patients (100%) complained of pain in the control group compared with 20 (56%), 22 (61%) and 23 (64%) in the lidocaine, thiopental and metoclopramide groups, respectively (p<0.05). there was no significant difference among the 3 test solution with regards to severity of pain. Nor were there any noted complications 24 hours postoperatively on the injection site. Conclusion: Thiopental and metoclopramide are equally effective as lidocaine in reducing pain during propofol injection when used with manual venous occlusion.
Human ; LIDOCAINE ; THIOPENTAL ; METOCLOPRAMIDE ; PROPOFOL ; PAIN MANAGEMENT ; ANESTHESIA

BACKGROUND: Postoperative nausea and vomiting is one of the main problems after mastoidectomy and tympanoplasty. There is a growing interest in the use of nonpharmacologic and nonintravenous approaches to the prevention of postoperative nausea and vomiting. The aim of this study was to investigate the effect of stimulating the P6 acupoint and of the use of metoclopramide intranasal spray on the prevention of postoperative nausea and vomiting after mastoidectomy and tympanoplasty. METHODS: We studied 60 patients who received mastoidectomy and tympanoplasty for chronic ottitis media. No antiemetic agent or device was provided in the C group (n = 20). Acupressure on the P6 acupoint was applied after surgery in the P6 group (n = 20). In the M group (n = 20), metoclopramide was sprayed intranasally before extubation. Severity values of postoperative nausea and vomiting were assessed using 5 scales at different postoperative times. RESULTS: The severity of postoperative nausea and vomiting was significantly lower in the P6 group than in the C and M groups. There was no difference in the severity of postoperative nausea and vomiting between the C and M groups. At a postoperative 8 and 16 hr, there was a statiscally significant decrease of the severity of postoperative nausea and vomiting in the P6 group. CONCLUSIONS: Acupressure on the P6 acupoint reduced the incidence and severity of postoperative nausea and vomiting after mastoidectiomy and tympanoplasty. This result suggests that acupressure at P6 may be a useful new nonpharmacologic approach to the reduction or prevention of postoperative nausea and vomiting after mastoidectomy and tympanoplasty.
Acupressure ; Acupuncture Points ; Humans ; Incidence ; Metoclopramide ; Nausea ; Postoperative Nausea and Vomiting* ; Tympanoplasty* ; Vomiting ; Weights and Measures